Terminated PHASE4 INTERVENTIONAL 2-arm NCT00955266

A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass

A Randomized Double-Blind Placebo-Controlled Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass

Sponsor: Brigham and Women's Hospital

Conditions Diastolic Dysfunction

Interventions Calcium Chloride Placebo

Updated 10 times since 2017 Last updated: Apr 10, 2017 Started: Jul 31, 2009 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inadequate recruitment

This PHASE4 trial investigates Diastolic Dysfunction and is currently terminated or withdrawn. Brigham and Women's Hospital leads this study, which shows 10 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4

▶ Show 5 earlier versions

Dec 2021 — Dec 2022 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jul 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Jul 2017 [monthly]

Terminated PHASE4

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States